Latest law Stories
WASHINGTON, April 21, 2015 /PRNewswire-USNewswire/ -- As news of a compromise in the U.S.
HOUSTON, April 21, 2015 /PRNewswire/ -- Sabine Oil & Gas Corporation (OTCQB:SOGC) (the "Company") today announced that it has elected to exercise its right to a grace period with respect
SAN ANTONIO, April 21, 2015 /PRNewswire/ -- The Board of Directors of Valero Energy Partners GP LLC, the general partner of Valero Energy Partners LP (NYSE: VLP, the Partnership), has approved
WARRENVILLE, Ill., April 21, 2015 /PRNewswire/ -- RMS-Recovery Management Services, Inc.
BOHEMIA, N.Y., April 21, 2015 /PRNewswire-iReach/ -- Whistleblowers Against Fraud (WAF) is a New York-based team of
BRADFORD, England, April 21, 2015 /PRNewswire/ -- Hosted Proclaim System Implemented by Leading Law Firm Leading south-east law firm, Centenary Solicitors,
HOUSTON, April 21, 2015 /PRNewswire/ -- Burleson LLP will host a second webinar on April 22 as part of its ongoing series titled, "Drilling Down on Strategic Alternatives in the Current Energy Crisis."
BURLINGAME, Calif., April 21, 2015 /PRNewswire/ -- AeroCentury Corp.
HOLON, Israel, April 21, 2015 /PRNewswire/ -- Sapiens International Corporation [http://www.sapiens.com ], (NASDAQ and TASE: SPNS), a leading global provider of software
Bernstein Liebhard LLP is representing Lipitor lawsuit plaintiffs in the federal proceeding established in District of South Carolina for product liability claims alleging the statin medication
The OncoMouse or Harvard Mouse is a type of laboratory mouse that has been genetically modified utilizing modification designed by Philip Leder and Timothy A. Stewart, of Harvard University, to carry a certain gene called an activated oncogene. The activated oncogene considerably increases the mouse’s vulnerability to cancer, therefore making the mouse suitable for cancer research. The rights to the invention were owned by DuPont until recently. The USPTO found that the patent expired in...
More Images (1 images) »